home / stock / opti:cc / opti:cc quote
Last: | $0.275 |
---|---|
Change Percent: | -3.51% |
Open: | $0.285 |
Close: | $0.275 |
High: | $0.285 |
Low: | $0.275 |
Volume: | 21,514 |
Last Trade Date Time: | 05/06/2022 04:57:13 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.275 | $0.285 | $0.275 | $0.285 | $0.275 | 21,514 | 05-06-2022 |
$0.275 | $0.28 | $0.275 | $0.29 | $0.275 | 125,533 | 05-04-2022 |
$0.29 | $0.29 | $0.29 | $0.3 | $0.28 | 58,306 | 04-29-2022 |
$0.29 | $0.3 | $0.29 | $0.3 | $0.28 | 50,123 | 04-28-2022 |
$0.295 | $0.28 | $0.295 | $0.295 | $0.28 | 54,011 | 04-27-2022 |
$0.29 | $0.29 | $0.29 | $0.3 | $0.275 | 94,208 | 04-25-2022 |
$0.29 | $0.295 | $0.29 | $0.3 | $0.265 | 232,503 | 04-22-2022 |
$0.3 | $0.305 | $0.3 | $0.305 | $0.29 | 60,231 | 04-20-2022 |
$0.3 | $0.33 | $0.3 | $0.33 | $0.3 | 100,381 | 04-19-2022 |
$0.345 | $0.31 | $0.345 | $0.345 | $0.305 | 183,144 | 04-18-2022 |
$0.31 | $0.325 | $0.31 | $0.325 | $0.31 | 132,041 | 04-12-2022 |
$0.36 | $0.34 | $0.36 | $0.36 | $0.33 | 133,510 | 04-08-2022 |
$0.365 | $0.365 | $0.365 | $0.365 | $0.34 | 211,518 | 04-07-2022 |
$0.36 | $0.335 | $0.36 | $0.36 | $0.335 | 95,479 | 04-06-2022 |
$0.335 | $0.33 | $0.335 | $0.335 | $0.325 | 11,065 | 04-05-2022 |
$0.335 | $0.34 | $0.335 | $0.34 | $0.33 | 7,483 | 04-04-2022 |
$0.33 | $0.31 | $0.33 | $0.33 | $0.295 | 166,106 | 03-31-2022 |
$0.3 | $0.3 | $0.3 | $0.3 | $0.295 | 47,288 | 03-30-2022 |
$0.29 | $0.29 | $0.29 | $0.295 | $0.275 | 57,781 | 03-29-2022 |
$0.28 | $0.3 | $0.28 | $0.31 | $0.28 | 99,868 | 03-28-2022 |
News, Short Squeeze, Breakout and More Instantly...
Observational studies to focus on patients with addiction and end-of-life distress pending formal approval and permitting from Thai health authorities Vancouver, British Columbia--(Newsfile Corp. - July 23, 2024) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) (" Optimi " or the " Co...
Vancouver, British Columbia--(Newsfile Corp. - June 27, 2024) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) (" Optimi " or the " Company "), a Health Canada-approved, GMP-compliant pharmaceutical drug manufacturer specializing in the controlled substances MDMA and botanical psilocyb...
The Company will ship 160 doses of MDMA and psilocybin to Australian psychiatrists for the treatment of patients with PTSD and Treatment-Resistant Depression. Vancouver, British Columbia--(Newsfile Corp. - June 25, 2024) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ( "Optimi" o...